| 0.016 0.005 (41.59%) | 09-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.03  |
1-year : | 0.04 |
| Resists | First : | 0.02 |
Second : | 0.03 |
| Pivot price | 0.01 |
|||
| Supports | First : | 0.01 | Second : | 0 |
| MAs | MA(5) : | 0.01 |
MA(20) : | 0.01 |
| MA(100) : | 0.1 |
MA(250) : | 0.32 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 27.1 |
D(3) : | 19.5 |
| RSI | RSI(14): 35.4 |
|||
| 52-week | High : | 2.51 | Low : | 0 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VSEE ] has closed below upper band by 44.6%. Bollinger Bands are 84.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.02 - 0.02 | 0.02 - 0.02 |
| Low: | 0.01 - 0.01 | 0.01 - 0.01 |
| Close: | 0.02 - 0.02 | 0.02 - 0.02 |
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Wed, 09 Sep 2026
$5M stock sale deal lets VSee Health (VSEE) tap funding over 36 months - Stock Titan
Tue, 01 Sep 2026
VSee Health, Inc. announced that it expects to receive $5 million in funding from ClearThink Capital Partners, LLC - marketscreener.com
Mon, 31 Aug 2026
VSee Health (VSEE) loses board member as Metzger resigns - Stock Titan
Mon, 31 Aug 2026
Scott Metzger resigns from VSee Health board and compensation committee - TradingView
Fri, 31 Jul 2026
M&A: VSee Health to Acquire $35M Healthcare Commerce Platform - HIT Consultant
Thu, 30 Jul 2026
VSee Signs LOI for $42 Million Healthcare Platform Acquisition - citybiz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 57 (M) |
| Held by Insiders | 4.754e+007 (%) |
| Held by Institutions | 14.6 (%) |
| Shares Short | 1,050 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.25e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -62.6 % |
| Operating Margin | -172.7 % |
| Return on Assets (ttm) | -38.8 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 1.581e+007 % |
| Gross Profit (p.s.) | 120 |
| Sales Per Share | 1139.69 |
| EBITDA (p.s.) | 1.715e+007 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.04 |
| Dividend | 0 |
| Forward Dividend | 1.65e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|